Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...
They include semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound). GLP-1 receptor agonists can increase satiety, reduce appetite, and regulate blood sugar levels — all of ...